Armata presents at H.C. Wainwright conference; no new data in exhibit

Armata Pharmaceuticals, Inc.

CEO Dr. Deborah Birx presented at H.C. Wainwright 27th Annual Global Investment Conference on Sept 10, 2025.
Exhibit 99.1 contains only title slide and forward-looking disclaimers; no new clinical or financial data.
Prior $26.2M DoD award referenced in disclaimers; no update on program milestones or guidance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.